CAS 2166558-11-6

JNJ-55308942 (JNJ55308942)

Description:

JNJ-55308942, also known by its CAS number 2166558-11-6, is a small molecule that has been investigated primarily for its potential therapeutic applications in the treatment of various diseases, particularly in the field of oncology. It is classified as a selective inhibitor of certain protein kinases, which play a crucial role in cell signaling pathways that regulate cell growth and division. The compound's structure features specific functional groups that contribute to its biological activity and selectivity. In preclinical studies, JNJ-55308942 has shown promise in inhibiting tumor growth and may have a favorable pharmacokinetic profile, which includes properties such as absorption, distribution, metabolism, and excretion. However, as with many investigational drugs, its safety and efficacy in humans are still under evaluation through clinical trials. Understanding the characteristics of JNJ-55308942 is essential for researchers and clinicians as they explore its potential applications in targeted cancer therapies.

Formula: C₁₇H₁₂F₅N₇O

Synonyms:

• JNJ-55308942
• (JNJ55308942)

JNJ-55308942

CAS: 2166558-11-6

JNJ-55308942

Purity: ≥98%

Molecular weight: 425.32g/mol

Ref: 54-BUP07456

JNJ-55308942

CAS: 2166558-11-6

Formula: C₁₇H₁₂F₅N₇O

Molecular weight: 425.32

Ref: 4Z-J-007001

JNJ-55308942

CAS: 2166558-11-6

JNJ-55308942 is a human Chinese nalbuphine analog that has been found to have anticancer properties. It works by inhibiting kinases, which are enzymes that play a crucial role in cancer cell growth and survival. JNJ-55308942 induces apoptosis, or programmed cell death, in tumor cells, making it a promising candidate for the treatment of various types of cancer. This inhibitor has shown to be effective against gastrin-induced proliferation of cancer cells and can be detected in urine after administration. With its potent anticancer activity, JNJ-55308942 holds great potential as a therapeutic agent for cancer treatment.

Formula: C₁₇H₁₂F₅N₇O

Purity: Min. 95%

Molecular weight: 425.3 g/mol

Ref: 3D-RLD55811

JNJ-55308942

CAS: 2166558-11-6

JNJ-55308942: selective, brain-penetrant P2X7 antagonist; IC50s: 10nM (human), 15nM (rat); Kis: 7.1nM (h), 2.9nM (r).

Formula: C₁₇H₁₂F₅N₇O

Purity: 99.94%

Color and Shape: Solid

Molecular weight: 425.32

Ref: TM-T37806